Oxagen Limited - Company & Market Research Reports

Oxagen Limited is a privately-held biopharmaceutical company that works in collaboration with Eleventa LLC to develop and commercialise OC000459 for the Russian and CIS markets. OC000459 is a once-daily oral CRTH2 antagonist which has demonstrated encouraging activity in the treatment of eosinophilic asthma and allergic rhinoconjunctivitis, and an excellent safety profile. Oxagen Limited was incorporated in 1996 and is based in Abingdon, United Kingdom.

Allergic Asthma - Pipeline Review, H2 2016 - Product Thumbnail Image

Allergic Asthma - Pipeline Review, H2 2016

  • Report
  • 181 Pages
From
Allergic Asthma - Pipeline Review, H1 2016 - Product Thumbnail Image

Allergic Asthma - Pipeline Review, H1 2016

  • Report
  • 182 Pages
From
Allergic Asthma - Pipeline Review, H2 2015 - Product Thumbnail Image

Allergic Asthma - Pipeline Review, H2 2015

  • Report
  • 146 Pages
From
Allergic Rhino-Conjunctivitis - Pipeline Review, H2 2015 - Product Thumbnail Image

Allergic Rhino-Conjunctivitis - Pipeline Review, H2 2015

  • Report
  • 82 Pages
From
Global Bronchodilators Market 2017-2021 - Product Thumbnail Image

Global Bronchodilators Market 2017-2021

  • Report
  • 83 Pages
From
Global Asthma Therapeutics Market 2016-2020 - Product Thumbnail Image

Global Asthma Therapeutics Market 2016-2020

  • Report
  • 110 Pages
From
Asthma - Pipeline Review, H1 2018 - Product Thumbnail Image

Asthma - Pipeline Review, H1 2018

  • Report
  • 592 Pages
From
Dermatology Therapeutics Drug Development Pipeline Review, 2016 - Product Thumbnail Image

Dermatology Therapeutics Drug Development Pipeline Review, 2016

  • Report
  • 432 Pages
From
Atopic Dermatitis - Pipeline Review, H1 2018 - Product Thumbnail Image

Atopic Dermatitis - Pipeline Review, H1 2018

  • Report
  • 379 Pages
From
Dermatitis - Pipeline Review, H2 2015 - Product Thumbnail Image

Dermatitis - Pipeline Review, H2 2015

  • Report
  • 445 Pages
From
Dermatitis - Pipeline Review, H1 2015 - Product Thumbnail Image

Dermatitis - Pipeline Review, H1 2015

  • Report
  • 381 Pages
From
Rhino-Conjunctivitis - Pipeline Review, H1 2018 - Product Thumbnail Image

Rhino-Conjunctivitis - Pipeline Review, H1 2018

  • Report
  • 76 Pages
From
Prostaglandin D2 Receptor 2 (Chemoattractant Receptor Homologous Molecule Expressed On Th2 Cells or G Protein Coupled Receptor 44 or GPR44 or CD294 or PTGDR2) - Pipeline Review, H1 2018 - Product Thumbnail Image

Prostaglandin D2 Receptor 2 (Chemoattractant Receptor Homologous Molecule Expressed On Th2 Cells or G Protein Coupled Receptor 44 or GPR44 or CD294 or PTGDR2) - Pipeline Review, H1 2018

  • Report
  • 54 Pages
From
Inflammation - Pipeline Review, H1 2014 - Product Thumbnail Image

Inflammation - Pipeline Review, H1 2014

  • Report
  • 1103 Pages
From
Prostaglandin D2 Receptor 2 (Chemoattractant Receptor-Homologous Molecule Expressed On Th2 Cells or G-Protein Coupled Receptor 44 or CD294 or DP2 or PTGDR2) - Pipeline Review, H1 2016 - Product Thumbnail Image

Prostaglandin D2 Receptor 2 (Chemoattractant Receptor-Homologous Molecule Expressed On Th2 Cells or G-Protein Coupled Receptor 44 or CD294 or DP2 or PTGDR2) - Pipeline Review, H1 2016

  • Report
  • 59 Pages
From
  • 15 Results (Page 1 of 1)
Loading Indicator
adroll